Oscar Health, Inc. (OSCR)
Last Price$15.13.3%
Market Cap$3,703.3M
OSCR Rating
OSCR Quality rating performance
OSCR Intrinsic Value
Key Highlights:
As of Mar 03, 2025 OSCR Relative Value is $23.6, which is undervalued by 56.6%, compared to current share price of $15.1.
As of Mar 03, 2025 OSCR DCF Value is N/A, which is undervalued by N/A, compared to current share price of $15.1.
OSCR Share Price History
1W (1.2%)
1M (9.9%)
6M (16.0%)
YTD 65.8%
1Y (1.7%)
3Y 121.6%
5Y (56.6%)
10Y (56.6%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
OSCR Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$3,703.3M
$1,851.2M
$9,177.6M
$950.3M
Shares Outstanding
245M
Employees
2,400
Growth (CAGR)
N/A
N/A
25.5%
583.85%
Profitability
100.0%
0.6%
10.7%
10.4%
3,638.1%
Intrinsic Value
$23.7 (57.0% undervalued)
N/A
$23.7
22.2%
Return on Capital
Financial Health
$2,151.6M
($1,852.1M)
(1.9x)
2.4x
29.5%
Dividends
Earnings
May 05, 2025
BEAT by 3.5%
MISS by 9.1%
(60.0%)
6 Beat & 4 Miss
OSCR Stock Financials
OSCR Income Statement Metrics
Annual
Quarterly
LTM
OSCR Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$978.2M N/A YoY
Capital Expenditure (CAPEX)
($27.9M) +9.1% YoY
Free Cash Flow (FCF)
$950.3M N/A YoY
OSCR Income Statement Overview
Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$9,177.6M 56.5% YoY
Pre-tax income
$33.4M 0.0% YoY
0.4% margin
OSCR Balance Sheet Overview
Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$4,840.5M
Current assets ($2,845.2M, 58.8% of total)
$2,151.6M (44.5%)
$315.9M (6.5%)
Other current assets
$377.6M (7.8%)
Non-current assets ($1,995.3M, 41.2% of total)
$1,815.3M (37.5%)
$66.8M (1.4%)
$0.0 (0.0%)
Other non-current assets
$113.3M (2.3%)
Financial position
($1,852.1M)
Cash & Short-term
Investments
Total Debt
OSCR Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
OSCR Earnings Surprises
Crunching data... Almost there!
OSCR Dividends
OSCR Dividend Yield
Crunching data... Almost there!
OSCR Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with OSCR
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
FAQ
What is Oscar Health, Inc. (OSCR) stock rating?
As of today, Oscar Health, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is Oscar Health, Inc. (OSCR) a good stock to buy?
As of today, Oscar Health, Inc. has a Good stock rating, which is 57.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.